Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 412

Similar articles for PubMed (Select 15450648)

1.

Consensus statement on office-based treatment of opioid dependence using buprenorphine.

Fiellin DA, Kleber H, Trumble-Hejduk JG, McLellan AT, Kosten TR.

J Subst Abuse Treat. 2004 Sep;27(2):153-9. Review.

PMID:
15450648
2.

Buprenorphine for office-based treatment of patients with opioid addiction.

Manlandro JJ Jr.

J Am Osteopath Assoc. 2005 Jun;105(6 Suppl 3):S8-13. Review.

PMID:
16118361
3.

Buprenorphine for office-based practice: consensus conference overview.

Kosten TR, Fiellin DA; U.S. National Buprenorphine Implementation Program.

Am J Addict. 2004;13 Suppl 1:S1-7. Review.

PMID:
15204671
4.

Bupreorphine:a new pharmacotherapy for opioid addictions treatment.

Stock C, Shum JH.

J Pain Palliat Care Pharmacother. 2004;18(3):35-54. Review.

PMID:
15364630
5.

Buprenorphine for the treatment of opioid dependence.

Boothby LA, Doering PL.

Am J Health Syst Pharm. 2007 Feb 1;64(3):266-72. Review.

PMID:
17244875
6.
7.

Opioid dependence treatment, including buprenorphine/naloxone.

Raisch DW, Fye CL, Boardman KD, Sather MR.

Ann Pharmacother. 2002 Feb;36(2):312-21. Review.

PMID:
11847954
8.

Buprenorphine and addiction: challenges for the pharmacist.

Boatwright DE.

J Am Pharm Assoc (Wash). 2002 May-Jun;42(3):432-8.

PMID:
12030630
9.

Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.

Gerra G, Borella F, Zaimovic A, Moi G, Bussandri M, Bubici C, Bertacca S.

Drug Alcohol Depend. 2004 Jul 15;75(1):37-45.

PMID:
15225887
10.

Managing opioid addiction with buprenorphine.

Donaher PA, Welsh C.

Am Fam Physician. 2006 May 1;73(9):1573-8. Review.

11.

Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care.

Schackman BR, Leff JA, Polsky D, Moore BA, Fiellin DA.

J Gen Intern Med. 2012 Jun;27(6):669-76. doi: 10.1007/s11606-011-1962-8. Epub 2012 Jan 4.

12.

Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction.

Kraus ML, Alford DP, Kotz MM, Levounis P, Mandell TW, Meyer M, Salsitz EA, Wetterau N, Wyatt SA; American Society Of Addiction Medicine.

J Addict Med. 2011 Dec;5(4):254-63. doi: 10.1097/ADM.0b013e3182312983.

PMID:
22042215
13.

Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.

Arfken CL, Johanson CE, di Menza S, Schuster CR.

J Subst Abuse Treat. 2010 Sep;39(2):96-104. doi: 10.1016/j.jsat.2010.05.004. Epub 2010 Jul 3.

PMID:
20598829
14.

Office-based buprenorphine treatment for opioid-dependent patients.

McCance-Katz EF.

Harv Rev Psychiatry. 2004 Nov-Dec;12(6):321-38. Review.

PMID:
15764468
15.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
16.

Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.

Parran TV, Adelman CA, Merkin B, Pagano ME, Defranco R, Ionescu RA, Mace AG.

Drug Alcohol Depend. 2010 Jan 1;106(1):56-60. doi: 10.1016/j.drugalcdep.2009.07.013. Epub 2009 Aug 29.

17.

Using buprenorphine for outpatient opioid detoxification.

Manlandro JJ Jr.

J Am Osteopath Assoc. 2007 Sep;107(9 Suppl 5):ES11-6. Review.

PMID:
17908825
18.

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.

Am J Addict. 2004;13 Suppl 1:S42-66.

19.

Naltrexone and buprenorphine combination in the treatment of opioid dependence.

Gerra G, Fantoma A, Zaimovic A.

J Psychopharmacol. 2006 Nov;20(6):806-14. Epub 2006 Jan 9.

PMID:
16401652
20.

Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S.

Ann Fam Med. 2007 Mar-Apr;5(2):146-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk